{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:01:32Z","timestamp":1766023292713,"version":"3.48.0"},"reference-count":31,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/xgup6698","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:52:03Z","timestamp":1748573523000},"page":"3252-3260","source":"Crossref","is-referenced-by-count":0,"title":["Serum levels of Galectin-1 and Galectin-3 for monitoring rheumatoid arthritis severity: a meta-analysis"],"prefix":"10.62347","volume":"17","author":[{"given":"Chunyan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.rdc.2022.02.010","article-title":"Rheumatoid arthritis: early diagnosis and treatment","volume":"48","author":"Cush","year":"2022","unstructured":"Cush JJ. Rheumatoid arthritis: early diagnosis and treatment. Rheum Dis Clin North Am 2022; 48: 537-547.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.medcli.2023.07.014","article-title":"Rheumatoid arthritis","volume":"161","author":"D&#xED","year":"2023","unstructured":"Díaz-González F and Hernández-Hernández MV. Rheumatoid arthritis. Med Clin (Barc) 2023; 161: 533-542.","journal-title":"Med Clin (Barc)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13075-023-03049-z","article-title":"Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels","volume":"25","author":"Chen","year":"2023","unstructured":"Chen J, Li S, Zhu J, Su W, Jian C, Zhang J, Wu J, Wang T, Zhang W, Zeng F, Chang S, Jia L, Su J, Zhao Y, Wang J and Zeng F. Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels. Arthritis Res Ther 2023; 25: 74.","journal-title":"Arthritis Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Matteo A","year":"2023","unstructured":"Di Matteo A, Bathon JM and Emery P. Rheumatoid arthritis. Lancet 2023; 402: 2019-2033.","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Roldán-Montero R, Pérez-Sáez JM, Cerro-Pardo I, Oller J, Martinez-Lopez D, Nuñez E, Maller SM, Gutierrez-Muñoz C, Mendez-Barbero N, Escola-Gil JC, Michel JB, Mittelbrunn M, Vázquez J, Blanco-Colio LM, Rabinovich GA and Martin-Ventura JL. Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm. Sci Adv 2022; 8: eabm7322.","DOI":"10.1126\/sciadv.abm7322"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.3390\/ijms24076501","article-title":"Galectin-1: a traditionally immunosuppressive protein displays context-dependent capacities","volume":"24","author":"Yu","year":"2023","unstructured":"Yu X, Qian J, Ding L, Yin S, Zhou L and Zheng S. Galectin-1: a traditionally immunosuppressive protein displays context-dependent capacities. Int J Mol Sci 2023; 24: 6501.","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"15500","DOI":"10.3390\/ijms242115500","article-title":"Galectin-1 in pancreatic ductal adenocarcinoma: bridging tumor biology, immune evasion, and therapeutic opportunities","volume":"24","author":"Bogut","year":"2023","unstructured":"Bogut A, Stojanovic B, Jovanovic M, Dimitrijevic Stojanovic M, Gajovic N, Stojanovic BS, Balovic G, Jovanovic M, Lazovic A, Mirovic M, Jurisevic M, Jovanovic I and Mladenovic V. Galectin-1 in pancreatic ductal adenocarcinoma: bridging tumor biology, immune evasion, and therapeutic opportunities. Int J Mol Sci 2023; 24: 15500.","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1381612827666210927164935","article-title":"Therapeutic potential of Galectin-1 and Galectin-3 in autoimmune diseases","volume":"28","author":"YS","year":"2022","unstructured":"He YS, Hu YQ, Xiang K, Chen Y, Feng YT, Yin KJ, Huang JX, Wang J, Wu ZD, Wang GH and Pan HF. Therapeutic potential of Galectin-1 and Galectin-3 in autoimmune diseases. Curr Pharm Des 2022; 28: 36-45.","journal-title":"Curr Pharm Des"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"155020","DOI":"10.1016\/j.cyto.2020.155020","article-title":"Peptidomic analysis on synovial tissue reveals galectin-1 derived peptide as a potential bioactive molecule against rheumatoid arthritis","volume":"131","author":"Hu","year":"2020","unstructured":"Hu J, Lu J, Zhang X, Wang C, Ren K, Chang Q, Ji M, Pan W, Ma B and Fan W. Peptidomic analysis on synovial tissue reveals galectin-1 derived peptide as a potential bioactive molecule against rheumatoid arthritis. Cytokine 2020; 131: 155020.","journal-title":"Cytokine"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"920273","DOI":"10.3389\/fgene.2022.920273","article-title":"p53: a regulator of ferroptosis induced by Galectin-1 derived peptide 3 in MH7A Cells","volume":"13","author":"Hu","year":"2022","unstructured":"Hu J, Zhang R, Chang Q, Ji M, Zhang H, Geng R, Li C and Wang Z. p53: a regulator of ferroptosis induced by Galectin-1 derived peptide 3 in MH7A Cells. Front Genet 2022; 13: 920273.","journal-title":"Front Genet"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Yáñez-Baeza C, Aguilera-Eguía RA, Fuentes-Barría H and Roco-Videla Á. Importance of the PRISMA guideline. Nutr Hosp 2023; 40: 670-675.","DOI":"10.20960\/nh.04616"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.3389\/fimmu.2018.03057","article-title":"Clinical relevance of Galectin-1 and Galectin-3 in rheumatoid arthritis patients: differential regulation and correlation with disease activity","volume":"9","author":"Mendez-Huergo SP","year":"2018","unstructured":"Mendez-Huergo SP, Hockl PF, Stupirski JC, Maller SM, Morosi LG, Pinto NA, Berón AM, Musuruana JL, Nasswetter GG, Cavallasca JA and Rabinovich GA. Clinical relevance of Galectin-1 and Galectin-3 in rheumatoid arthritis patients: differential regulation and correlation with disease activity. Front Immunol 2018; 9: 3057.","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.55133\/eji.300207","article-title":"Galectin-1 in psoriatic arthritis, psoriasis, rheumatoid arthritis and its relation with disease activity and skin lesion","volume":"30","author":"El Bably","year":"2023","unstructured":"El Bably MM, Abdel Aziz DM, Adly NN, Ali MA, Khedr AS and El Leithy SA. Galectin-1 in psoriatic arthritis, psoriasis, rheumatoid arthritis and its relation with disease activity and skin lesion. Egypt J Immunol 2023; 30: 73-82.","journal-title":"Egypt J Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6313","DOI":"10.3390\/jcm11216313","article-title":"Galectin-1: a potential biomarker differentiating between early rheumatoid arthritis and spondyloarthritis","volume":"11","author":"Triguero-Mart&#xED","year":"2022","unstructured":"Triguero-Martínez A, Roy-Vallejo E, Tomero EG, Montes N, Fuente H, Ortiz AM, Castañeda S, Lamana A and González-Álvaro I. Galectin-1: a potential biomarker differentiating between early rheumatoid arthritis and spondyloarthritis. J Clin Med 2022; 11: 6313.","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"17799","DOI":"10.1038\/s41598-020-74185-8","article-title":"Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis","volume":"10","author":"Triguero-Mart&#xED","year":"2020","unstructured":"Triguero-Martínez A, de la Fuente H, Montes N, Ortiz AM, Roy-Vallejo E, Castañeda S, González-Alvaro I and Lamana A. Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis. Sci Rep 2020; 10: 17799.","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"116309","DOI":"10.1016\/j.bmc.2021.116309","article-title":"Structural insights in galectin-1-glycan recognition: relevance of the glycosidic linkage and the N-acetylation pattern of sugar moieties","volume":"44","author":"Porci&#xFA","year":"2021","unstructured":"Porciúncula-González C, Cagnoni AJ, Fontana C, Mariño KV, Saenz-Méndez P, Giacomini C and Irazoqui G. Structural insights in galectin-1-glycan recognition: relevance of the glycosidic linkage and the N-acetylation pattern of sugar moieties. Bioorg Med Chem 2021; 44: 116309.","journal-title":"Bioorg Med Chem"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1073\/pnas.1922778117","article-title":"Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits","volume":"117","author":"Mart&#xED","year":"2020","unstructured":"Martínez Allo VC, Hauk V, Sarbia N, Pinto NA, Croci DO, Dalotto-Moreno T, Morales RM, Gatto SG, Manselle Cocco MN, Stupirski JC, Deladoey Á, Maronna E, Marcaida P, Durigan V, Secco A, Mamani M, Dos Santos A, Catalán Pellet A, Pérez Leiros C, Rabinovich GA and Toscano MA. Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits. Proc Natl Acad Sci U S A 2020; 117: 6630-6639.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13287-017-0691-2","article-title":"Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility","volume":"8","author":"Reesink","year":"2017","unstructured":"Reesink HL, Sutton RM, Shurer CR, Peterson RP, Tan JS, Su J, Paszek MJ and Nixon AJ. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility. Stem Cell Res Ther 2017; 8: 243.","journal-title":"Stem Cell Res Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fvets.2018.00288","article-title":"Galectins-1 and-3 increase in equine post-traumatic osteoarthritis","volume":"5","author":"Reesink","year":"2018","unstructured":"Reesink HL, Nixon AJ, Su J, Liu S, Sutton RM, Mann S, Watts AE and Peterson RP. Galectins-1 and-3 increase in equine post-traumatic osteoarthritis. Front Vet Sci 2018; 5: 288.","journal-title":"Front Vet Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"112788","DOI":"10.1016\/j.yexcr.2021.112788","article-title":"Galectin-1 secreted by bone marrow-derived mesenchymal stem cells mediates anti-inflammatory responses in acute airway disease","volume":"407","author":"Ge","year":"2021","unstructured":"Ge X, Shi K, Hou J, Fu Y, Xiao H, Chi F, Xu J, Cai F and Bai C. Galectin-1 secreted by bone marrow-derived mesenchymal stem cells mediates anti-inflammatory responses in acute airway disease. Exp Cell Res 2021; 407: 112788.","journal-title":"Exp Cell Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/glycob\/cwab007","article-title":"Tissue-specific control of galectin-1-driven circuits during inflammatory responses","volume":"31","author":"Cutine","year":"2021","unstructured":"Cutine AM, Bach CA, Veigas F, Merlo JP, Laporte L, Manselle Cocco MN, Massaro M, Sarbia N, Perrotta RM, Mahmoud YD and Rabinovich GA. Tissue-specific control of galectin-1-driven circuits during inflammatory responses. Glycobiology 2021; 31: 891-907.","journal-title":"Glycobiology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.kint.2022.04.020","article-title":"Bruceine a protects against diabetic kidney disease via inhibiting galectin-1","volume":"102","author":"Li","year":"2022","unstructured":"Li H, Zhao X, Zheng L, Wang X, Lin S, Shen J, Ren H, Li Y, Qiu Q and Wang Z. Bruceine a protects against diabetic kidney disease via inhibiting galectin-1. Kidney Int 2022; 102: 521-535.","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Modarresi Chahardehi A, Masoumi SA, Bigdeloo M, Arsad H and Lim V. The effect of exercise on patients with rheumatoid arthritis on the modulation of inflammation. Clin Exp Rheumatol 2022; 40: 1420-1431.","DOI":"10.55563\/clinexprheumatol\/fohyoy"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/rheumatology\/keac693","article-title":"A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘plants for joints’ randomized controlled trial","volume":"62","author":"Walrabenstein","year":"2023","unstructured":"Walrabenstein W, Wagenaar CA, van der Leeden M, Turkstra F, Twisk JWR, Boers M, van Middendorp H, Weijs PJM and van Schaardenburg D. A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘plants for joints’ randomized controlled trial. Rheumatology (Oxford) 2023; 62: 2683-2691.","journal-title":"Rheumatology (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/03009742.2012.725769","article-title":"A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis","volume":"42","author":"Xibill&#xE9","year":"2013","unstructured":"Xibillé-Friedmann D, Bustos Rivera-Bahena C, Rojas-Serrano J, Burgos-Vargas R and Montiel-Hernández JL. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand J Rheumatol 2013; 42: 102-107.","journal-title":"Scand J Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/sji.12619","article-title":"Galectin-3 is persistently increased in early rheumatoid arthritis (RA) and associates with anti-CCP seropositivity and MRI bone lesions, while early fibrosis markers correlate with disease activity","volume":"86","author":"SF","year":"2017","unstructured":"Issa SF, Christensen AF, Lindegaard HM, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K, Ejbjerg BJ, Lottenburger T, Ellingsen T, Pedersen JK, Junker K, Svendsen A, Tarp U, Østergaard M and Junker P. Galectin-3 is persistently increased in early rheumatoid arthritis (RA) and associates with anti-CCP seropositivity and MRI bone lesions, while early fibrosis markers correlate with disease activity. Scand J Immunol 2017; 86: 471-478.","journal-title":"Scand J Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"152357","DOI":"10.1016\/j.semarthrit.2023.152357","article-title":"Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis","volume":"65","author":"Nussdorf","year":"2024","unstructured":"Nussdorf A, Park E, Amigues I, Geraldino-Pardilla L, Bokhari S, Giles JT and Bathon JM. Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis. Semin Arthritis Rheum 2024; 65: 152357.","journal-title":"Semin Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/clc.23105","article-title":"Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis","volume":"42","author":"Anyfanti","year":"2019","unstructured":"Anyfanti P, Gkaliagkousi E, Gavriilaki E, Triantafyllou A, Dolgyras P, Galanopoulou V, Aslanidis S and Douma S. Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis. Clin Cardiol 2019; 42: 62-68.","journal-title":"Clin Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.3390\/jcm9103312","article-title":"Diagnostic power of Galectin-3 in rheumatic diseases","volume":"9","author":"Gruszewska","year":"2020","unstructured":"Gruszewska E, Cylwik B, Gińdzieńska-Sieśkiewicz E, Kowal-Bielecka O, Mroczko B and Chrostek L. Diagnostic power of Galectin-3 in rheumatic diseases. J Clin Med 2020; 9: 3312.","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/03009742.2021.1992860","article-title":"Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis","volume":"52","author":"MA","year":"2023","unstructured":"Nielsen MA, Køster D, Greisen S, Troldborg A, Stengaard-Pedersen K, Junker P, Hørslev-Petersen K, Hetland ML, Østergaard M, Hvid M, Leffler H, Kragstrup TW and Deleuran B. Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis. Scand J Rheumatol 2023; 52: 33-41.","journal-title":"Scand J Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/sji.12301","article-title":"Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals","volume":"82","author":"SF","year":"2015","unstructured":"Issa SF, Christensen AF, Lottenburger T, Junker K, Lindegaard H, Hørslev-Petersen K and Junker P. Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals. Scand J Immunol 2015; 82: 70-75.","journal-title":"Scand J Immunol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0162920.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:38Z","timestamp":1766022998000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0162920.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/xgup6698","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}